Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Ingvild Odsbu"'
Autor:
Ingeborg Hartz, Nils Henry Haugen Madsstuen, Per Normann Andersen, Marte Handal, Ingvild Odsbu
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background The use of medication for Attention-Deficit/Hyperactivity Disorder (ADHD) increased globally throughout the early 2000s. This study examine trends in prevalences and incidences of medication use in Norway from 2006 to 2022. Method
Externí odkaz:
https://doaj.org/article/18a76e4828a04c018cfedbb790670e45
Publikováno v:
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Knowledge of co-occurring mental disorders (termed ‘dual diagnosis’) among patients receiving opioid agonist treatment (OAT) is scarce. This study aimed (1) to estimate the prevalence and structure of dual diagnoses in two nat
Externí odkaz:
https://doaj.org/article/310d9b23dc4341008ae3f87572077137
Autor:
Christian J Bachmann, Oliver Scholle, Mette Bliddal, Susan dosReis, Ingvild Odsbu, Svetlana Skurtveit, Rikke Wesselhoeft, Annika Vivirito, Chengchen Zhang, Stephen Scott
Publikováno v:
Child and Adolescent Psychiatry and Mental Health, Vol 18, Iss 1, Pp 1-11 (2024)
Abstract Background Conduct disorders (CD) are among the most frequent psychiatric disorders in children and adolescents, with an estimated worldwide prevalence in the community of 2–4%. Evidence-based psychological outpatient treatment leads to si
Externí odkaz:
https://doaj.org/article/4caa435d2cd94f5abf5020ffc1474a40
Autor:
Gabriela Rolová, Desiree Eide, Roman Gabrhelík, Ingvild Odsbu, Thomas Clausen, Svetlana Skurtveit
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background Physical diseases represent a significant burden for opioid agonist treatment (OAT) patients. This study described physical morbidity in two national cohorts of OAT patients focusing on gender differences. Methods This population-
Externí odkaz:
https://doaj.org/article/6b1ed96f5c1c4362ba95ac71fed6f169
Autor:
Ingvild Odsbu, Marte Handal, Vidar Hjellvik, Sonia Hernandez-Diaz, Helle Kieler, Mette Nørgaard, Svetlana Skurtveit, Buket Öztürk Esen, Milada Mahic
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Opioids may modulate the immune function through opioid receptors on immune cells. Long-term consequences of prenatal opioid exposure on the immune system, such as childhood asthma, are unknown.Objectives: To investigate whether prenatal
Externí odkaz:
https://doaj.org/article/f66b63f39f694333a9eacd15f2cc3c0c
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Increased and inappropriate antimicrobial use are the key drivers of the emergence of antimicrobial resistance, and there have been widespread concerns around potential antimicrobial misuse, overuse and their consequences during t
Externí odkaz:
https://doaj.org/article/d2e3294d193141978365a3dc8c987993
Autor:
Christer F. Aas, Jørn Henrik Vold, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Aaron G. Lim, Kjell Arne Johansson, Lars Thore Fadnes
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 15, Iss 1, Pp 1-10 (2020)
Abstract Background Treatment with direct-acting antiviral agents (DAAs) offers an opportunity to eliminate hepatitis C virus (HCV) endemic among people who inject drugs (PWID) and people enrolled in opioid agonist therapy (OAT) programs. The objecti
Externí odkaz:
https://doaj.org/article/e392f5a6d51441f1aed9eed7188bc832
Autor:
Jørn Henrik Vold, Christer Aas, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Anne Halmøy, Kjell Arne Johansson, Lars Thore Fadnes
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background It is estimated that up to a third of patients on opioid agonist therapy (OAT) have attention deficit hyperactivity disorder (ADHD). Treatment by ADHD medication, including a centrally acting stimulant (CAS) or atomoxetine is one
Externí odkaz:
https://doaj.org/article/ed9efb24d3aa44c7a10fc2667196622b
Autor:
Laura Pazzagli, Silvia Segovia Chacón, Christos Karampelias, Jacqueline M Cohen, Gabriella Bröms, Helle Kieler, Ingvild Odsbu, Randi Selmer, Olov Andersson, Carolyn E Cesta
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272046 (2022)
IntroductionInconsistent results have been reported on the association between folic acid use in pregnancy and risk of GDM. The aim of this study was to estimate the association between folic acid use and GDM in two population-based Nordic cohorts.Ma
Externí odkaz:
https://doaj.org/article/e08f10d0c08c4cf8b0e7a6ada4d6ef70
Publikováno v:
Norsk Epidemiologi, Vol 29, Iss 1-2 (2021)
Aim: We aimed to describe opioid maintenance treatment (OMT) to pregnant women in Norway and study the background characteristics of the pregnant women compared to the general population of pregnant women and to a previous clinical cohort study of OM
Externí odkaz:
https://doaj.org/article/b4032c8fe9b440efbd1b84cca28c40ea